Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
Author(s) -
Paul D. Brown,
Kurt A. Jaeckle,
Karla V. Ballman,
Elana Farace,
Jane H. Cerhan,
S. Keith Anderson,
Xiomara W. Carrero,
Fred G. Barker,
Richard L. Deming,
Stuart H. Burri,
Cynthia Ménard,
Caroline Chung,
Volker W. Stieber,
Bruce E. Pollock,
Evanthia Galanis,
Jan C. Buckner,
Anthony L. Asher
Publication year - 2016
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2016.9839
Subject(s) - medicine , radiosurgery , quality of life (healthcare) , randomized controlled trial , cognition , radiation therapy , clinical endpoint , cognitive decline , dementia , disease , nursing , psychiatry
Whole brain radiotherapy (WBRT) significantly improves tumor control in the brain after stereotactic radiosurgery (SRS), yet because of its association with cognitive decline, its role in the treatment of patients with brain metastases remains controversial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom